InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-37.6%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by HILL BARBARA B, Director. Director active across 2 companies, notably Integra Lifesciences Holdings CORP. Aggregated, 8 reports have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €917k. History available since 14 May 2021. The latest transaction was disclosed on 9 May 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations8 total
6,939 shares0Common StockSEC:0000917520-25-000046:0
36,350 shares@ US$27.3952100.0% of flowCommon StockSEC:0000917520-24-000075:0
Ideal exit: 15 Feb 2025 (T+270)
3,163 shares0Common StockSEC:0000917520-24-000068:0
1,631 shares0Common StockSEC:0001209191-23-029801:0
1,265 shares0Common StockSEC:0001209191-22-029716:0
1,060 shares0Common StockSEC:0001209191-21-033131
1,060 shares0Common StockSEC:0001209191-21-033131:0
8,800 sharesCommon StockSEC:0001179110-16-018645:0
8 of 8 declarations
About HILL BARBARA B
Barbara B. Hill is a Director at Integra LifeSciences Holdings Corp. In this role, she participates in the governance of the company, providing her expertise in strategy and healthcare. Barbara plays a key role in the strategic direction of Integra, a company specializing in medical devices.
